Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Brain Res ; 1634: 75-82, 2016 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-26746340

RESUMEN

Spinal cord injury (SCI) often results in some form of paralysis. Recently, SCI therapy has been focused on preventing secondary injury to reduce both neuroinflammation and lesion size so that functional outcome after an SCI may be improved. Previous studies have shown that adenosine receptors (AR) are a major regulator of inflammation after an SCI. The current study was performed to examine the effect of caffeine, a pan-AR blocker, on spontaneous functional recovery after an SCI. Animals were assigned into 3 groups randomly, including sham, PBS and caffeine groups. The rat SCI was generated by an NYU impactor with a 10 g rod dropped from a 25 mm height at thoracic 9 spinal cord level. Caffeine and PBS were injected daily during the experiment period. Hind limb motor function was evaluated by the Basso, Beattie, Bresnahan (BBB) locomotor rating scale at 1 week and 4 weeks after the SCI. Spinal cord segments were collected after final behavior evaluation for morphological analysis. The tissue sparing was evaluated by luxol fast blue staining. Immunofluorescence stain was employed to assess astrocyte activation and neurofilament positioning, while microglia activation was examined by immunohistochemistry stain.The results showed that spontaneous functional recovery was blocked after the animals were subjected caffeine daily. Moreover, caffeine administration increased the demyelination area, promoted astrocyte and microglia activation and decreased the quantity of neurofilaments. These findings suggest that the neurotoxicity effect of caffeine may be associated with the inhibition of neural repair and the promotion of neuroinflammation.


Asunto(s)
Cafeína/toxicidad , Encefalitis/fisiopatología , Antagonistas de Receptores Purinérgicos P1/toxicidad , Recuperación de la Función/efectos de los fármacos , Traumatismos de la Médula Espinal/fisiopatología , Animales , Astrocitos/efectos de los fármacos , Astrocitos/fisiología , Encefalitis/etiología , Miembro Posterior/fisiopatología , Filamentos Intermedios/efectos de los fármacos , Filamentos Intermedios/metabolismo , Masculino , Microglía/efectos de los fármacos , Microglía/fisiología , Actividad Motora/efectos de los fármacos , Vaina de Mielina/efectos de los fármacos , Ratas , Ratas Sprague-Dawley , Traumatismos de la Médula Espinal/complicaciones , Traumatismos de la Médula Espinal/patología
2.
Indian J Exp Biol ; 52(12): 1165-72, 2014 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-25651609

RESUMEN

Meclizine and caffeine combination is used for the treatment of morning sickness. Both compounds are teratogenic and caffeine is known to possess anti-fertility activity also. The present study was undertaken to evaluate the reproductive toxic effect of meclizine and caffeine combination. Three doses were taken for the study; low dose (LD; meclizine 3.7 mg/kg and caffeine 3 mg/kg) was selected from commercially available formulation, middle dose (MD; meclizine 37 mg/kg and caffeine 30 mg/kg) and high dose (HD; meclizine 370 mg/kg and caffeine 300 mg/kg). The mixture was administered 1-7 days and 8-14 days for fertility and embryotoxic studies respectively. Laparotomy was done on 10t day of gestation period. Number of implants and corpora lutea were counted, pre and post-implantation losses were determined. In embryo toxicity study fetuses were evaluated for external, skeletal and visceral examination. High dose was removed from both fertility and embryotoxicity studies due to its severe toxicity to the dam. Significant anti-fertility activity was observed at middle dose. Embryotoxicity study showed significant reduction in fetal body weight, body length and body mass index, dam body weight gain on gestation day 14. Absolute kidney weight in MD and absolute and relative spleen weight in both LD and MD were significantly reduced. There was no increase in external or internal congenital anomalies at both LD and MD. The, results suggest that prescription of meclizine and caffeine for morning sickness in early pregnancy should be reviewed carefully.


Asunto(s)
Peso Corporal/efectos de los fármacos , Cafeína/toxicidad , Ingestión de Alimentos/efectos de los fármacos , Fertilidad/efectos de los fármacos , Meclizina/toxicidad , Aumento de Peso/efectos de los fármacos , Anomalías Inducidas por Medicamentos/etiología , Administración Oral , Animales , Cafeína/administración & dosificación , Relación Dosis-Respuesta a Droga , Combinación de Medicamentos , Desarrollo Embrionario/efectos de los fármacos , Femenino , Peso Fetal/efectos de los fármacos , Edad Gestacional , Antagonistas de los Receptores Histamínicos H1/administración & dosificación , Antagonistas de los Receptores Histamínicos H1/toxicidad , Riñón/efectos de los fármacos , Riñón/patología , Hígado/efectos de los fármacos , Hígado/patología , Masculino , Meclizina/administración & dosificación , Tamaño de los Órganos/efectos de los fármacos , Antagonistas de Receptores Purinérgicos P1/administración & dosificación , Antagonistas de Receptores Purinérgicos P1/toxicidad , Ratas Wistar , Bazo/efectos de los fármacos , Bazo/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA